MTI Onyx V. Aneurysm Coil Trial Protocol Revisited; PMA On Track For 2004
This article was originally published in The Gray Sheet
Executive Summary
Micro Therapeutics' revised inclusion criteria for its U.S. pivotal trial comparing the Onyx LES liquid embolic system with Boston Scientific's GDC Ultrasoft coil to treat brain aneurysms will delay PMA filing by three fiscal quarters, MTI estimates